Skip to main content
Bengaluru: Lancet study flags concerns over HCQ, finds no tangible benefit yet - Times of India 26-May-2020
Bengaluru: Lancet study flags concerns over HCQ, finds no tangible benefit yet - Times of India
A recent research study published in Lancet on antimalarial drug hydroxychloroquine (HCQ), used to treat Covid-19 patients, not offering any benefit
More...